Akero Therapeutics Company

Akero Therapeutics is a clinical-stage company developing transformational therapies for people with metabolic dysfunction-associated steatohepatitis (MASH).

Investors

Connections from

Headquarters: United States
Employee Number: 56
Founded Date: 2017.0
Industry: Biotechnology
Technology: Biotechnology
Register and Claim Ownership